Transcranial magnetic stimulation (TMS) is ever evolving with new clinical indications increasing at a rapid pace. Using TMS, this group of studies aims to explore whether we can help treat various substance use disorders.

Transcranial magnetic stimulation (TMS) is one of the newer treatments available to Veterans to help alleviate symptoms of depression. Using fMRI, EEG, and blood based markers of neurogenesis, this group of studies aims to explore whether we can predict who will benefit most from this treatment modality.

As we age, our bodies have encountered a variety of experiences (good and bad) which impact our ability to fight off illness. Using state of the art statistical analysis of archived health study data, we assess how different illnesses impact late life cognition.